CHICAGO (Reuters) - Diagnostic test maker Gen-Probe Inc is again hunting for acquisition targets in Europe, two months after walking away from a proposed $335 million takeover of Innogenetics NV , its ...
Diagnostic products maker Gen-Probe Inc. (:GPRO) has secured the approval of the U.S. Food and Drug Administration ("FDA") for its PROGENSA PCA3 assay, a novel molecular test designed to aid the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback